CMS Is Removing PET Scan Restrictions for Alzheimer’s Patients

The Centers for Medicare & Medicaid Services (CMS) has decided to remove the national coverage determination (NCD) that limits patients’ ability to qualify for new drugs, giving people with Alzheimer’s disease symptoms a better path to treating the condition.

The policy means amyloid PET scans will no longer be limited and will give patients a better chance of being prescribed a drug like Eisai’s Leqembi, which clears beta amyloid proteins from the brain to slow the advances of Alzheimer’s.

Source: https://www.fiercehealthcare.com/payers/cms-removing-pet-scan-restrictions-alzheimers-patients